We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Amit Tirosh

Amit Tirosh MD

Head, NET Service, Division of Endocrinology, Sheba Medical Center, Israel

Dr. Amit Tirosh is an endocrinologist who specializes in inherited syndromes related to the development of neuroendocrine tumors. He is Head of Neuroendocrine Tumors Services at the Institute of Endocrinology at Sheba Medical Center (MC) in Israel. Additionally, Dr. Tirosh is Principal Investigator in the Endocrine Oncology Genomics Laboratory at Sheba MC; Director of the National VHL Alliance Designated Clinical Care Center in Israel; Expert Clinician at ClinGen VHL Information Sharing International cONsortium (VISION); and Assistant Professor of Medicine in the Sackler Faculty of Medicine, Tel Aviv University.  

Dr. Tirosh has published widely and conducts active research in the bioinformatics of endocrine cancer in general and of neuroendocrine tumors in particular. He serves as a member of the US National Institutes of Health (NIH) in the field of MEN1 syndrome. He serves as Chair of the Pancreatic Manifestations Guidelines Subcommittee of the VHL Alliance in Boston, Massachusetts, where he is also a member of the Clinical Advisory Council. 

Dr. Tirosh received his medical degree from Hadassah Medical School at Hebrew University in Jerusalem. He underwent residency training in internal medicine at Assaf Harofe in Be'er Ya'akov, Israel, and completed a fellowship in endocrinology, diabetes, and metabolism at the Rabin Medical Center in Petach Tikva, Israel. 

He was a visiting fellow in the Section on Genetics and Endocrinology at the National Institute of Child Health and Human Development at the NIH, and a post-doctoral fellow at the Endocrine Oncology Branch of the National Cancer Institute at NIH. 

He is a member of the Israeli Society of Endocrinology, the American Endocrine Society, and the European Neuroendocrine Tumors Society.